Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
Nakama T, Yoshida S, Ishikawa K, Kobayashi Y, Zhou Y, Nakao S, Sassa Y, Oshima Y, Takao K, Shimahara A, Yoshikawa K, Hamasaki T, Ohgi T, Hayashi H, Matsuda A, Kudo A, Nozaki M, Ogura Y, Kuroda M, Ishibashi T.
Nakama T, et al. Among authors: ishikawa k.
Gene Ther. 2015 Feb;22(2):127-37. doi: 10.1038/gt.2014.112. Epub 2014 Dec 11.
Gene Ther. 2015.
PMID: 25503692